21 C.F.R. § 207.55

What additional drug listing information may FDA require?

Last amended: 2016Year: 2026Length: 46 wordsOfficial source

Cite as 21 C.F.R. § 207.55 (2026)

For a particular listed drug, upon our request, the registrant must briefly state the basis for its belief that the drug is not subject to section 505 or 512 of the Federal Food, Drug, and Cosmetic Act or section 351 of the Public Health Service Act.
21 C.F.R. § 207.55: What additional drug listing information may FDA require? | Justis AI